2,2',3,3'-Tetrahydro-1,1'-spirobi[indene]-7,7'-diol, 95.0%, 25g

2-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine hydrochloride, 95.0%, 10g

Ethyl 3,4-difluorobenzoate, 97.0%, 500g

3-Fluoro-DL-phenylalanine>98.0%(HPLC)(T)5g

2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 95%, 100mg

Juego de diapositivas de contraste de fase con objetivos PLPHi IOS de 20x y S100x con corrección de infinito y anillos de contraste de fase para 20x/S100x

6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3R)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine, 98.0%, 100mg

1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 50g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid, 98%, 1g

3-Fluoro-4-(2-fluorophenoxy)aniline, 98%, 1g

METHYL 2,2-DIPHENYLACETATE, 95.0%, 500g

Éter de petróleo 40-60 °C, 2,5 l, vidrio

4-Bromo-5-chloronaphthalen-2-ol, 97%, 100mg